Oppenheimer & Co’s Loxo Oncology, Inc LOXO Stock Holding History

Oppenheimer & Co’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,790	Closed	-$251K	–	1406
2018 Q4	$251K	Buy	+1,790	New	+$272K	0.01%	1017

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Oppenheimer & Co's LOXO Position: Q1 2019 in Review

Oppenheimer & Co sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 1,790 shares — an estimated $251K sold.

Oppenheimer & Co first reported a position in LOXO in Q4 2018 and held it in 1 quarter. The position peaked at $251K in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Oppenheimer & Co reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Oppenheimer & Co sold 1,790 Loxo Oncology, Inc shares in Q1 2019, an estimated $251K.
Oppenheimer & Co first reported a position in Loxo Oncology, Inc in Q4 2018 and held it in 1 quarter.
Oppenheimer & Co's Loxo Oncology, Inc position peaked at $251K in Q4 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Oppenheimer & Co's 13F filing for Q1 2019, filed 24 Apr 2019.